The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C

Drugs under Experimental and Clinical Research

Volumn 22, Issue 6, 1996, Pages 287-294

  Amtmann, E ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPASE D; PHOSPHORYLCHOLINE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BINDING;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BINDING, COMPETITIVE; BRIDGED COMPOUNDS; CATTLE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASE C; THIONES;

EID: 0030480576     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Curren T. The fos oncogene. In: Reddy E.P., Skalka A.M., Curren T (eds) "Oncogene Handbook." Elsevier/North-Holland, Amsterdam, 1988, pp. 307-325.
2. Verma E.M., Sassone-Corsi P. Proto-oncogene fos: complex out versatile regulation. Cell, 51, 513-514, 1987.
3. Exton J. H. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta, 1212, 26-42, 1994.
4. Dennis E.A. Phospholipases. In: Boyer P.D., (ed) "The Enzymes". Vol. 16. Academic Press, New York, 1983, pp 307-333.
5. Exlon J.H. Phospholipase D in cell signalling and its relationship to phospholipase C. J. Biol. Chem., 265, 1-4, 1990.
6. Billah M.M., Anthes J.C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J., 269, 282-291, 1990.
7. Shukla S.D., Halenda S.P. Phospholipase D in cell signalling and its relationship to phospholipase C. Life Sci.. 48. 851-866, 1991.
8. Cockcroft S. G-protein-regulated phospholipases C, D and A2-mediated signalling in neutrophils. Biochim. Biophys. Acta., 1113, 135-160, 1992.
9. Nabel G., Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature, 326, 711-713, 1987.
10. Sauer G, et al. DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc. Natl. Acad. Sci. (USA), 81, 3263-3267, 1984.
11. Amtmann E, Hummel K., Sauer G. The therapeutic efficacy of a xanthate compound on herpes simplex virus in skin lesions of mice and guinea-pigs. J. Gen. Virol., 66, 1953-1960, 1985.
12. Amtmann E., Müller K., Knapp A., Sauer G. Reversion of bovine papilloma virus-induced transformation and immortalization by a xanthate compound. Exp. Cell. Res., 161, 541-550, 1985.
13. Doppler C., Schalasta G., Amtmann E., Sauer G. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity. AIDS Res. Hum. Retroviruses, 8, 245-252, 1992.
14. Music L., Sauer G. Inhibition of Moloney murine leukemiavirus transcription by a phospholipase C inhibitor effecting transcription factors. Antiviral. Chem. Chemother., 3/5, 283-291, 1992.
15. Otten N. et al. A contribution to the therapy of equine sarcoids: experimental treatment using a xanthate compound and recombinant human tumor necrosis factor. J. Vet. Med. A., 41, 757-765, 1994.
16. Müller-Decker K. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem. Biophys. Res. Commun., 162, 198-205, 1989.
17. Schütze S., Potthoff K., Berkovic D., Wiegmann K., Krönke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell, 71, 765-776, 1992.
18. Kurioka S., Matsuda M. Phospholipase C assay using p-nitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal. Biochem., 75, 281-289, 1976.
19. Villanueva N., Navarro J., Cubero B. Antiviral effects of xanthate 0609 on the human respiratory syncytial virus growth cycle. Virology, 181, 101-108, 1991.